Tobacco cessation pharmacotherapy use among racial/ethnic minorities in the United States: Considerations for primary care

Monica W Hooper, Michael Payne, Kimberly A. Parkinson

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Pharmacotherapies for tobacco cessation are efficacious and recommended during quit attempts. Racial/ethnic minorities in the United States are less likely to use medication-based aids for tobacco cessation, despite greater difficulty achieving long-term abstinence. The reasons for this include, among others, provider- and patient-level considerations. Primary care clinicians play an important role in encouraging racial/ethnic minority tobacco users to use cessation pharmacotherapy. To better understand pharmacotherapy use, we conducted a narrative review of patient-level factors that may determine uptake and adherence. This review indicates that social and cultural factors impact pharmacotherapy use, including health care experiences, beliefs, perceptions, and norms. The proportion of individuals using pharmacotherapy during quit attempts and adhering to the full course of treatment may be enhanced with greater attention to the ethnocultural concerns of these groups. Culturally appropriate assessment and brief advice delivered by primary care providers could yield significant benefits in population health. Recommendations for treating racial/ethnic tobacco users with pharmacotherapy for cessation are offered.

Original languageEnglish (US)
Pages (from-to)193-203
Number of pages11
JournalFamily Medicine and Community Health
Volume5
Issue number3
DOIs
StatePublished - Oct 1 2017
Externally publishedYes

Fingerprint

Tobacco Use Cessation
Primary Health Care
Drug Therapy
Tobacco
Delivery of Health Care
Health
Population

Keywords

  • Bupropion
  • Nicotine replacement therapy
  • Pharmacotherapy
  • Physician advice
  • Primary care
  • Racial/ethnic minorities
  • Tobacco cessation
  • Varenicline

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Family Practice

Cite this

Tobacco cessation pharmacotherapy use among racial/ethnic minorities in the United States : Considerations for primary care. / Hooper, Monica W; Payne, Michael; Parkinson, Kimberly A.

In: Family Medicine and Community Health, Vol. 5, No. 3, 01.10.2017, p. 193-203.

Research output: Contribution to journalArticle

@article{5ee95458726446158114ce3164dd4238,
title = "Tobacco cessation pharmacotherapy use among racial/ethnic minorities in the United States: Considerations for primary care",
abstract = "Pharmacotherapies for tobacco cessation are efficacious and recommended during quit attempts. Racial/ethnic minorities in the United States are less likely to use medication-based aids for tobacco cessation, despite greater difficulty achieving long-term abstinence. The reasons for this include, among others, provider- and patient-level considerations. Primary care clinicians play an important role in encouraging racial/ethnic minority tobacco users to use cessation pharmacotherapy. To better understand pharmacotherapy use, we conducted a narrative review of patient-level factors that may determine uptake and adherence. This review indicates that social and cultural factors impact pharmacotherapy use, including health care experiences, beliefs, perceptions, and norms. The proportion of individuals using pharmacotherapy during quit attempts and adhering to the full course of treatment may be enhanced with greater attention to the ethnocultural concerns of these groups. Culturally appropriate assessment and brief advice delivered by primary care providers could yield significant benefits in population health. Recommendations for treating racial/ethnic tobacco users with pharmacotherapy for cessation are offered.",
keywords = "Bupropion, Nicotine replacement therapy, Pharmacotherapy, Physician advice, Primary care, Racial/ethnic minorities, Tobacco cessation, Varenicline",
author = "Hooper, {Monica W} and Michael Payne and Parkinson, {Kimberly A.}",
year = "2017",
month = "10",
day = "1",
doi = "10.15212/FMCH.2017.0138",
language = "English (US)",
volume = "5",
pages = "193--203",
journal = "Family Medicine and Community Health",
issn = "2305-6983",
publisher = "Compuscript Ltd.",
number = "3",

}

TY - JOUR

T1 - Tobacco cessation pharmacotherapy use among racial/ethnic minorities in the United States

T2 - Considerations for primary care

AU - Hooper, Monica W

AU - Payne, Michael

AU - Parkinson, Kimberly A.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Pharmacotherapies for tobacco cessation are efficacious and recommended during quit attempts. Racial/ethnic minorities in the United States are less likely to use medication-based aids for tobacco cessation, despite greater difficulty achieving long-term abstinence. The reasons for this include, among others, provider- and patient-level considerations. Primary care clinicians play an important role in encouraging racial/ethnic minority tobacco users to use cessation pharmacotherapy. To better understand pharmacotherapy use, we conducted a narrative review of patient-level factors that may determine uptake and adherence. This review indicates that social and cultural factors impact pharmacotherapy use, including health care experiences, beliefs, perceptions, and norms. The proportion of individuals using pharmacotherapy during quit attempts and adhering to the full course of treatment may be enhanced with greater attention to the ethnocultural concerns of these groups. Culturally appropriate assessment and brief advice delivered by primary care providers could yield significant benefits in population health. Recommendations for treating racial/ethnic tobacco users with pharmacotherapy for cessation are offered.

AB - Pharmacotherapies for tobacco cessation are efficacious and recommended during quit attempts. Racial/ethnic minorities in the United States are less likely to use medication-based aids for tobacco cessation, despite greater difficulty achieving long-term abstinence. The reasons for this include, among others, provider- and patient-level considerations. Primary care clinicians play an important role in encouraging racial/ethnic minority tobacco users to use cessation pharmacotherapy. To better understand pharmacotherapy use, we conducted a narrative review of patient-level factors that may determine uptake and adherence. This review indicates that social and cultural factors impact pharmacotherapy use, including health care experiences, beliefs, perceptions, and norms. The proportion of individuals using pharmacotherapy during quit attempts and adhering to the full course of treatment may be enhanced with greater attention to the ethnocultural concerns of these groups. Culturally appropriate assessment and brief advice delivered by primary care providers could yield significant benefits in population health. Recommendations for treating racial/ethnic tobacco users with pharmacotherapy for cessation are offered.

KW - Bupropion

KW - Nicotine replacement therapy

KW - Pharmacotherapy

KW - Physician advice

KW - Primary care

KW - Racial/ethnic minorities

KW - Tobacco cessation

KW - Varenicline

UR - http://www.scopus.com/inward/record.url?scp=85033378982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033378982&partnerID=8YFLogxK

U2 - 10.15212/FMCH.2017.0138

DO - 10.15212/FMCH.2017.0138

M3 - Article

AN - SCOPUS:85033378982

VL - 5

SP - 193

EP - 203

JO - Family Medicine and Community Health

JF - Family Medicine and Community Health

SN - 2305-6983

IS - 3

ER -